Asensus Surgical Inc (ASXC)

[TraderAKA]

Even Da Vinci sold in Europe is less than 25% of what ISRG sold in the US. Even though, Da Vinci was approved in EU 2 years before it got approval from FDA in the US.

EU and US markets are largely different. So, scaremongers can keep beating the drum has nothing in common with the reality.

TRXC deserves some time to ramp up their sales. TRXC board of advisors all have positions at hospitals, I believe they will drive the sales back to those hospitals. As more hospitals buy the sales will pick up even faster.